Cargando…

Therapeutic Targeting Steroid Resistant Pro-Inflammatory NK and NKT-Like Cells in Chronic Inflammatory Lung Disease

The innate immune system drives the initiation of inflammation and progression to chronic inflammation in two important chronic inflammatory lung diseases involving the small airways, chronic obstructive pulmonary disease (COPD) and bronchiolitis obliterans syndrome (BOS), following lung transplanta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hodge, Greg, Hodge, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471110/ https://www.ncbi.nlm.nih.gov/pubmed/30917554 http://dx.doi.org/10.3390/ijms20061511

Ejemplares similares

Steroid Resistant CD8(+)CD28(null) NKT-Like Pro-inflammatory Cytotoxic Cells in Chronic Obstructive Pulmonary Disease
por: Hodge, Greg, et al.
Publicado: (2016)

Lymphocyte senescence in COPD is associated with decreased sirtuin 1 expression in steroid resistant pro-inflammatory lymphocytes
por: Hodge, Greg, et al.
Publicado: (2020)

Steroid resistance in COPD is associated with impaired molecular chaperone Hsp90 expression by pro-inflammatory lymphocytes
por: Hodge, Greg, et al.
Publicado: (2016)

BLTR1 Is Decreased in Steroid Resistant Pro-Inflammatory CD28nullCD8+ T Lymphocytes in Patients with COPD—The Spillover Hypothesis Explained?
por: Hodge, Greg, et al.
Publicado: (2023)

The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPD
por: Hodge, Greg, et al.
Publicado: (2013)

Targeting peripheral blood pro-inflammatory cytotoxic lymphocytes by inhibiting CD137 expression: novel potential treatment for COPD
por: Hodge, Greg, et al.
Publicado: (2014)

Lymphocyte senescence in COPD is associated with loss of glucocorticoid receptor expression by pro-inflammatory/cytotoxic lymphocytes
por: Hodge, Greg, et al.
Publicado: (2015)

Lymphocyte senescence in COPD is associated with decreased histone deacetylase 2 expression by pro-inflammatory lymphocytes
por: Hodge, Greg, et al.
Publicado: (2015)

NK and NKT-Like Cells in Patients with Recurrent Furunculosis
por: Nowicka, Danuta, et al.
Publicado: (2017)

Increased Peripheral Blood Pro-Inflammatory/Cytotoxic Lymphocytes in Children with Bronchiectasis
por: Hodge, G., et al.
Publicado: (2015)

Bushfire smoke is pro-inflammatory and suppresses macrophage phagocytic function
por: Hamon, Rhys, et al.
Publicado: (2018)

Differential inhibitory and activating NK cell receptor levels and NK/NKT-like cell functionality in chronic and recovered stages of chikungunya
por: Thanapati, Subrat, et al.
Publicado: (2017)

Increased Numbers of NK Cells, NKT-Like Cells, and NK Inhibitory Receptors in Peripheral Blood of Patients with Chronic Obstructive Pulmonary Disease
por: Tang, Ying, et al.
Publicado: (2013)

Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking
por: Eriksson Ström, Jonas, et al.
Publicado: (2018)

iNKT Cells in Secondary Progressive Multiple Sclerosis Patients Display Pro-inflammatory Profiles
por: De Biasi, Sara, et al.
Publicado: (2016)

Impaired NK and NKT cells immunobiology in rheumatoid arthritis
por: Aggarwal, Ashish, et al.
Publicado: (2012)

NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis
por: Sokhatska, Oksana, et al.
Publicado: (2019)

Pro- and Anti-Inflammatory Cytokines in the Context of NK Cell–Trophoblast Interactions
por: Mikhailova, Valentina, et al.
Publicado: (2022)

Phenotypic and functional analyses of NK and NKT-like populations during the early stages of chikungunya infection
por: Thanapati, Subrat, et al.
Publicado: (2015)

Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
por: Smyth, Mark J., et al.
Publicado: (2000)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020)

Roles and therapeutic potential of CD1d-Restricted NKT cells in inflammatory skin diseases
por: Lee, Sung Won, et al.
Publicado: (2022)

Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets
por: Szebeni, Gabor J., et al.
Publicado: (2016)

Defective Lung Macrophage Function in Lung Cancer±Chronic Obstructive Pulmonary Disease (COPD/Emphysema)-Mediated by Cancer Cell Production of PGE2?
por: Dehle, Francis C., et al.
Publicado: (2013)

miR-150 regulates the development of NK and iNKT cells
por: Bezman, Natalie A., et al.
Publicado: (2011)

NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies
por: Shimizu, Kanako, et al.
Publicado: (2020)

Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease
por: Durham, Andrew L., et al.
Publicado: (2016)

Pro-Inflammatory Activated Kupffer Cells by Lipids Induce Hepatic NKT Cells Deficiency through Activation-Induced Cell Death
por: Tang, Tongfang, et al.
Publicado: (2013)

Natural Born Killers: NK Cells in Cancer Therapy
por: Franks, S. Elizabeth, et al.
Publicado: (2020)

The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders
por: Johnson, M. Brittany, et al.
Publicado: (2017)

Augmentation of NKT and NK cell-mediated cytotoxicity by peptidoglycan monomer linked with zinc.
por: Mrakovcić-Sutić, Ines, et al.
Publicado: (2002)

Anaplasma phagocytophilum-Related Defects in CD8, NKT, and NK Lymphocyte Cytotoxicity
por: Scorpio, Diana G., et al.
Publicado: (2018)

IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells
por: Watkinson, Fiona, et al.
Publicado: (2021)

Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs
por: Bonamichi, Beatriz Dal Santo Francisco, et al.
Publicado: (2017)

Repeated Activation of Lung Invariant NKT Cells Results in Chronic Obstructive Pulmonary Disease-Like Symptoms
por: Tsao, Cheng-Chiu, et al.
Publicado: (2016)

Lectins Offer New Perspectives in the Development of Macrophage-Targeted Therapies for COPD/Emphysema
por: Mukaro, Violet R., et al.
Publicado: (2013)

Circulating NK cell subsets and NKT-like cells in renal transplant recipients with acute T-cell-mediated renal allograft rejection
por: Xu, Xiaoguang, et al.
Publicado: (2019)

Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia
por: Valhondo, Isabel, et al.
Publicado: (2020)

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer
por: Smyth, Mark J., et al.
Publicado: (2005)

Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pokrh5s2tg291rga99f4gco0b3